on 6 April 2022, Shenzhen Zhong Ji Health Science Company Limited signed a commodity supply contract with Sinopharm Holdings Hubei Guoda Pharmacy Co,. Ltd. The signing of the Supply Contract marks the formal formation of a strategic partnership between the two parties, which is the first step of the Group's retail coverage in Mainland China after obtaining the legal rights to distribute ZJ1 VC Extended-Release Tablets, a biological product from the United States, on the Mainland. The Group's next endeavour is continuously enhancing the development and collaboration with the top 100 offline pharmaceutical retailers in China, with a view to developing a more convenient physical channel for the public.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.246 HKD | +0.41% | +13.36% | +82.22% |
1st Jan change | Capi. | |
---|---|---|
+82.22% | 14.01M | |
-7.96% | 50.03B | |
-6.04% | 30.54B | |
+53.53% | 27.29B | |
+26.39% | 24.77B | |
+14.01% | 17.99B | |
+0.95% | 13.03B | |
+13.81% | 10.71B | |
+15.70% | 8.21B | |
-29.45% | 7.49B |
- Stock Market
- Equities
- 767 Stock
- News Zhong Ji Longevity Science Group Limited
- Shenzhen Zhong Ji Health Science Company Limited Signs A Commodity Supply Contract with Sinopharm Holdings Hubei Guoda Pharmacy Co,. Ltd